Company intelligence / Profile preview

Vesica AI

Tsukuba, Ibaraki, Japan

Ownership: Private
Development stage: Other

Overview

Vesica AI has developed an AI-based diagnostic software to assist cystoscopy-based detection for early diagnosis of bladder cancer, validated by top institutions in Japan and the United States, showing high accuracy in initial published research

Therapeutic areas: Oncology
Modalities: DeviceSoftware (AI-based)
Industry: Medical Imaging

Partnerships

Olympus Corporation (mentorship, innovation program partnership for clinical development and support)University of Tsukuba Hospital (collaborative clinical research)National Institute of Advanced Industrial Science and Technology (AIST), Japan

Beyond the preview

Go deeper on Vesica AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vesica AI.

Explore the full profile